Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (101-110 of 349) with videos related to

Pageof 35
Sort By:
Nature Reviews. Urology|February 24, 2021
Advances in the selection of patients with prostate cancer for active surveillanceJames L Liu, Hiten D Patel, Nora M Haney, et al.
Statistics in Medicine|October 15, 2013
Modeling grade progression in an active surveillance studyLurdes Y T Inoue, Bruce J Trock, Alan W Partin, et al.
Urology|December 12, 2002
Substratification of stage T1C prostate cancer based on the probability of biochemical recurrenceMatthew B Gretzer, Jonathan I Epstein, Charles R Pound, et al.
Urology|January 18, 2002
Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomyKiaran J O'Malley, Charles R Pound, Patrick C Walsh, et al.
Urology|July 15, 2010
Prediction of mortality after radical prostatectomy by Charlson comorbidity indexThomas J Guzzo, Paul Dluzniewski, Ryan Orosco, et al.
The Journal of Urology|March 23, 2011
Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasiaLance A Mynderse, Claus G Roehrborn, Alan W Partin, et al.
Cancer|October 8, 2004
Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomyCraig G Rogers, Masood A Khan, M Craig Miller, et al.
The Journal of Urology|November 19, 2013
Re: detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study: I. Y. Kim, P. K. Modi, E. Sadimin, Y.-S. Ha, J. H. Kim, D. Skarecky, D. Y. Cha, C. O. Wambi, Y.-C. Ou, B. Yuh, S. Park, E. Llukani, D. M. Albala, T. Wilson, T. Ahlering, K. Badani, H. Ahn, D. I. Lee, M. May, W.-J. Kim and d. H. Lee J Urol 2013;190:527-534Mark W Ball, Jeffrey K Mullins, Jonathan I Epstein, et al.
Transactions of the American Clinical and Climatological Association|January 10, 2017
CLINICAL EVALUATION OF AN EPIGENETIC ASSAY TO PREDICT MISSED CANCER IN PROSTATE BIOPSY SPECIMENSAlan W Partin, Wim VAN Criekinge, Bruce J Trock, et al.
The Prostate|August 9, 2017
Risk factors for metastatic prostate cancer: A sentinel event case seriesChanning J Paller, Alexander P Cole, Alan W Partin, et al.
Pageof 35

Showing results (101-110 of 349) with videos related to

Sort By:
Pageof 35
Nature Reviews. Urology|February 24, 2021
Advances in the selection of patients with prostate cancer for active surveillanceJames L Liu, Hiten D Patel, Nora M Haney, et al.
Statistics in Medicine|October 15, 2013
Modeling grade progression in an active surveillance studyLurdes Y T Inoue, Bruce J Trock, Alan W Partin, et al.
Urology|December 12, 2002
Substratification of stage T1C prostate cancer based on the probability of biochemical recurrenceMatthew B Gretzer, Jonathan I Epstein, Charles R Pound, et al.
Urology|January 18, 2002
Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomyKiaran J O'Malley, Charles R Pound, Patrick C Walsh, et al.
Urology|July 15, 2010
Prediction of mortality after radical prostatectomy by Charlson comorbidity indexThomas J Guzzo, Paul Dluzniewski, Ryan Orosco, et al.
The Journal of Urology|March 23, 2011
Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasiaLance A Mynderse, Claus G Roehrborn, Alan W Partin, et al.
Cancer|October 8, 2004
Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomyCraig G Rogers, Masood A Khan, M Craig Miller, et al.
The Journal of Urology|November 19, 2013
Re: detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study: I. Y. Kim, P. K. Modi, E. Sadimin, Y.-S. Ha, J. H. Kim, D. Skarecky, D. Y. Cha, C. O. Wambi, Y.-C. Ou, B. Yuh, S. Park, E. Llukani, D. M. Albala, T. Wilson, T. Ahlering, K. Badani, H. Ahn, D. I. Lee, M. May, W.-J. Kim and d. H. Lee J Urol 2013;190:527-534Mark W Ball, Jeffrey K Mullins, Jonathan I Epstein, et al.
Transactions of the American Clinical and Climatological Association|January 10, 2017
CLINICAL EVALUATION OF AN EPIGENETIC ASSAY TO PREDICT MISSED CANCER IN PROSTATE BIOPSY SPECIMENSAlan W Partin, Wim VAN Criekinge, Bruce J Trock, et al.
The Prostate|August 9, 2017
Risk factors for metastatic prostate cancer: A sentinel event case seriesChanning J Paller, Alexander P Cole, Alan W Partin, et al.
Pageof 35